A detailed history of Aufman Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Aufman Associates Inc holds 8,767 shares of MRNA stock, worth $345,332. This represents 0.38% of its overall portfolio holdings.

Number of Shares
8,767
Previous 6,506 34.75%
Holding current value
$345,332
Previous $772,000 24.22%
% of portfolio
0.38%
Previous 0.55%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $143,890 - $282,941
2,261 Added 34.75%
8,767 $585,000
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $223,269 - $367,541
2,206 Added 51.3%
6,506 $772,000
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $367,091 - $496,392
4,300 New
4,300 $458,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aufman Associates Inc Portfolio

Follow Aufman Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aufman Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aufman Associates Inc with notifications on news.